ADC Therapeutics SA
(ADCT)
undefined
undefined%
At close: undefined
1.88
0.53%
After-hours Dec 13, 2024, 07:50 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
Revenue | 69.56M | 209.91M | 33.92M | - | 2.34M | 1.14M | 1.80M |
Cost of Revenue | 2.53M | 4.58M | 1.39M | 1.97M | 107.54M | 118.09M | 85.53M |
Gross Profit | 67.03M | 205.33M | 32.52M | -1.97M | -105.20M | -116.95M | -83.73M |
Operating Income | -165.99M | -123.63M | -261.72M | -219.26M | -119.40M | -125.94M | -91.67M |
Interest Income | 10.54M | 17.97M | 66.00K | 832.00K | 2.25M | 2.86M | 1.03M |
Pretax Income | -195.42M | -154.66M | -251.50M | -245.96M | -115.90M | -122.87M | -89.81M |
Net Income | -240.05M | -155.80M | -230.03M | -246.29M | -116.48M | -123.10M | -89.86M |
Selling & General & Admin | 105.89M | 141.06M | 136.24M | 77.23M | 13.81M | 8.60M | 7.81M |
Research & Development | 127.13M | 187.90M | 158.00M | 142.03M | 107.54M | 118.31M | 85.53M |
Other Expenses | - | 14.58M | 28.49M | -46.40M | 388.00K | 166.00K | 137.00K |
Operating Expenses | 233.01M | 328.96M | 294.24M | 219.26M | 121.74M | 127.08M | 93.47M |
Interest Expense | 46.33M | 36.92M | 18.34M | 4.93M | 156.00K | - | - |
Selling & Marketing Expenses | 57.46M | 69.05M | 64.78M | 22.10M | - | - | - |
Cost & Expenses | 235.54M | 333.54M | 295.64M | 219.26M | 121.74M | 127.08M | 93.47M |
Income Tax | 39.11M | 1.14M | -21.48M | 327.00K | 582.00K | 224.00K | 48.00K |
Shares Outstanding (Basic) | 81.71M | 78.15M | 76.75M | 65.41M | 66.87M | 53.83M | 58.85M |
Shares Outstanding (Diluted) | 81.71M | 78.15M | 76.75M | 65.41M | 66.87M | 53.83M | 58.85M |
EPS (Basic) | -2.94 | -1.99 | -3 | -3.77 | -1.74 | -2.29 | -1.53 |
EPS (Diluted) | -2.94 | -1.99 | -3 | -3.77 | -1.74 | -2.29 | -1.53 |
EBITDA | -146.76M | -108.06M | -223.72M | -219.26M | -114.10M | -122.36M | -91.33M |
Depreciation & Amortization | 3.27M | 2.39M | 2.63M | 1.97M | 1.65M | 513.00K | 341.00K |